ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

165 hedge funds and large institutions have $930M invested in Esperion Therapeutics in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
-7
Holders Change %
-4.07%
% of All Funds
3.64%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
32
Increased
58
Reduced
48
Closed
36
Calls
$9.76M
Puts
$14.2M
Net Calls
-$4.41M
Net Calls Change
-$15M

Top Buyers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$41.7M
2
PIM
2
Platinum Investment Management
Australia
$25.6M
3
BG
3
Bellevue Group
Switzerland
$159M
4
WA
4
Wasatch Advisors
Utah
$28.6M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$6.33M

Top Sellers

1
Nomura Holdings
1
Nomura Holdings
Japan
$7.08M
2
Man Group
2
Man Group
United Kingdom
$200K
3
Millennium Management
3
Millennium Management
New York
$2.69M
4
TCM
4
Tekla Capital Management
Massachusetts
$1.31M
5
Goldman Sachs
5
Goldman Sachs
New York
$7.47M
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
201
IFP Advisors
Florida
– -$1K -9 Closed
5 6 7 8
9